Navigation Links
ResMed Announces Conference Call and Webcast to Discuss First Quarter 2012 Results
Date:9/13/2011

SAN DIEGO, Sept. 13, 2011 /PRNewswire/ -- RESMED INC. (NYSE: RMD), announced today that on Monday, October 24, 2011, it will release its results for the first quarter of fiscal year 2012, ended September 30, 2011. A press release with ResMed's results will be issued after 1:00 p.m. Pacific Time and the company will host a conference call and webcast to review its results, market trends, and future outlook.

(Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

The conference call is scheduled to begin at 1:30 p.m. Pacific Time and will be webcast on ResMed's website at http://investor.resmed.com.  Please go to this section of the website 5-10 minutes prior to the call and click on the icon for the "Q1 2012 results webcast". The online archive of the broadcast will be available approximately 30 minutes after the live call and will continue to be available for two weeks.International conference call times will be:9:30 p.m.

London7:30 a.m.

Sydney, Australia (October 25, 2011)TO PARTICIPATE in the conference call, please call one of the numbers below at least 10 minutes before the call begins and identify yourself to the operator:US:617-801-9715Outside US:  

+1 617-801-9715Conference Name:  

Q1 2012 ResMed Inc. Results Conference Call  Participant Passcode:

99214751The replay of the conference call will be available approximately 30 minutes after the call and will be accessible for two weeks at:US:

617-801-6888Outside US:+1 617-801-6888Passcode:

92613651ResMed is a global leader in the development, manufacturing and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. The company is dedicated to
'/>"/>

SOURCE ResMed Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ResMed Inc. to Present at Upcoming Conferences
2. CareFusion and ResMed Announce Distribution Agreement for U.S. Hospital Market
3. ResMed Announces Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year End 2011 Results
4. ResMed Announces Acquisition of BiancaMed
5. ResMed Announces New iPhone App
6. ResMed Inc. Announces Record Financial Results for the Quarter Ended and Nine Months Ended March 31, 2011
7. The Next Generation in Bilevel Therapy Now Available on ResMeds Award-Winning S9™ Platform
8. ResMed Announces Conference Call and Webcast to Discuss Third Quarter 2011 Results
9. ResMed Inc. Announces Management Changes
10. ResMed Inc. Announces Record Financial Results for the Quarter Ended and Six Months Ended December 31, 2010
11. ResMed Announces Conference Call and Webcast to Discuss Second Quarter 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... February 27, 2015 Report Details ... showing you trends, R&D progress, and predicted revenues ,Where ... What are the commercial prospects for this market and ... revenues and other trends to 2025, discussing data, opportunities ... you assess regenerative medicine : cell-based therapies that ...
(Date:2/27/2015)... 27, 2015 /CNW/ - Covalon Technologies Ltd. (the "Company" or ... announced financial results for its first quarter ended December ... ended December 31, 2014, revenue was $1,336,685. Operating expenses ... or $0.02 per share.  Covalon,s President ... very pleased with the significant progress we have made ...
(Date:2/27/2015)... 27, 2015 ... für kongestive Herzinsuffizienz (CHF) in seiner ersten ...     Die israelische ... Herzüberwachungssystem für Patienten mit kongestiver Herzinsuffizienz (CHF) ... ein Finanzierungsvorhaben über 5 Mio. USD abgeschlossen ...
Breaking Medicine Technology:Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2
... BRIDGEWATER, N.J., Sept. 17 Ortho Biotech has ... study,of the effects of Epoetin alfa in patients ... acute ischemic stroke who were treated with,Epoetin alfa ... symptoms died more,frequently than patients receiving placebo. Ortho ...
... 17 Sanofi pasteur, the,vaccines division of the ... Phase II clinical study exploring a multi-pronged treatment,approach ... often fatal form of,cancer for which there are ... United States and Canada. The trial, called MEL11, ...
Cached Medicine Technology:Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 2Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 3Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 4Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 5
(Date:3/2/2015)... 2015 Secura Consultants announced today ... First Protective Insurance Group of Birmingham, AL (First ... Protective affiliated advisors to access the enhanced disability ... Consultants delivers. , Secura Consultants, based ... the design and implementation of insured income protection ...
(Date:3/1/2015)... March 02, 2015 As residents ... works co-founders, Michael Burns and Carita Weaver, believe ... to working with the Southlake Chamber of Commerce, ... web works recently launched a website for Southlake ... A primary communications tool for Hill’s campaign, the ...
(Date:3/1/2015)... March 01, 2015 Comparing a new ... when using the Quotes Pros portal this year. A ... auto insurance rates that are being supplied through the ... updated agencies and prices available for each policy is ... online. Every system user will first be asked to ...
(Date:3/1/2015)... 2015 A federal court overseeing ... scheduled to go to trial in October has ... to provide testimony regarding the role an Italian ... Profemur device, Bernstein Liebhard LLP comments. According to ... District of Iowa on February 25th, Wright Medical ...
(Date:3/1/2015)... 01, 2015 Indiana Fiber Network, ... Provider, announces NewWays Networking, LLC (NewWays) selected IFN ... with IFN, NewWays is well positioned to scale ... for Internet bandwidth in rural parts of Indiana,” ... to Cory Childs IFN Enterprise Sales Manager, IFN ...
Breaking Medicine News(10 mins):Health News:Secura Consultants and First Protective Insurance Group Announce Strategic Relationship 2Health News:Website Launched for Southlake, Texas Mayoral Candidate Laura Hill 2Health News:United Auto Insurance Rates Now Quoted at Consumer Insurance Portal Online 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 3Health News:NewWays Networking Selects Indiana Fiber Network, LLC as Fiber Transport Provider 2
... out of the skin without pricking it makes for easier ... which uses the application of an electric field// to draw ... need for an injection. It could mean taking blood samples ... ,Researchers at the University of Texas, tried to ...
... become a reality some day, according to researchers who have ... strength and endurance. ,With this basic knowledge in ... that pumps up muscle cells without all that exercise, said ... School of Medicine. The main target of the study is ...
... from the plants Camellia sinensis contains polyphenols in the ... gives the tea its antioxidant properties. Polyphenols protect the ... , Oxidation produces ... in the body and an increased amount of them ...
... which they say has proved 100% precise in early ... brain,// and has been devised to learn from experience ... the University of British Columbia, by Peter Liddle, a ... the brain scan of patients looking for certain characteristics ...
... psychiatrist has discovered that treating patients with oestrogen can ... drugs like risperidone have been shown to help many ... suspected for some time that oestrogen can help protect ... the disease than men and it usually strikes them ...
... began two days of public hearings to decide whether ... a doctor's prescription. A number of medications are being ... pills. But there are inconsistent views about how this ... ,Prescription drug usage has risen in recent years, due, ...
Cached Medicine News:
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
Medicine Products: